TEST 2026 PRACTICE QUESTIONS AND
ACCURATE ANSWERS GRADED A+
◉ FDA approved medications for Tardive Dyskinesia:. Answer:
Ingrezza/valbenazine and Austedo/deutetrabenazine
◉ A life-threatening idiopathic reaction to antipsychotic medication
that is considered a medical emergency if left untreated:. Answer:
Neuroleptic Malignant Syndrome (NMS)
◉ Characteristics of NMS (triad):. Answer: Fever, Muscle Rigidity,
AMS
◉ FGA - which come in long-acting injectables:. Answer:
Fluphenazine/Prolixin
Haloperidol/Haldol
◉ SGA - which come in long-acting injectables:. Answer:
Risperidone/Risperdal
Paliperidone/Invega
Aripiprazole/Abilify
, Olanzapine/Zyprexa
◉ SGA associated with greatest prolactin elevation:. Answer:
Risperdal
◉ Weight neutral SGAs:. Answer: ziprasidone, abilify. (latuda?)
◉ Only SGA shown shown to decrease SI risks:. Answer: Clozapine
◉ SGA assocaited with agranulocytosis and 30-80% sialorrhea:.
Answer: Clozapine
◉ Clozapine treatment should be interrupted when ANC is below:.
Answer: 1000
◉ T/F: Patients started on Clozapine need to be registered in the
Clozapine REMS system. Answer: T
◉ A patient newly started on Clozapine will require ANC Monitoring
__________ x ___________ months. Answer: Weekly for 6 months
◉ Parameters that require monitoring at baseline and ongoing once
a patient is started on an SGA:. Answer: Weight, BMI, BP, FBG/AIC,
FLP